13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 43 holding rows worth $368,224,000.
- Accession
- 0001493152-20-021547
- Filer
- CIK 1582844
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 43 entries on the cover page, a total value of $368,224,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $368,224,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOMEDICS INC | 452907108 | COM | 511,500 | $43,493,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 973,000 | $29,813,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 250,000 | $27,858,000 | thousands by filing date | put |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,545,000 | $22,912,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 225,000 | $13,752,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 390,000 | $13,611,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 830,000 | $12,591,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 667,500 | $12,429,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 1,646,700 | $12,202,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 853,000 | $12,121,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 417,500 | $10,713,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 277,000 | $10,421,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 315,000 | $10,370,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 688,000 | $9,082,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 250,000 | $8,798,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 357,500 | $7,740,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 240,000 | $7,728,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 560,000 | $7,616,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,088,000 | $7,507,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 362,500 | $6,692,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 235,000 | $6,615,000 | thousands by filing date | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 1,497,900 | $6,441,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 2,364,204 | $5,863,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 765,000 | $5,539,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 167,054 | $5,040,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 802,500 | $4,526,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 101,500 | $4,371,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 305,900 | $4,341,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 392,500 | $4,318,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 705,218 | $3,554,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 240,744 | $3,553,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP | 698102209 | UNIT 99/99/9999 | 280,000 | $3,360,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 110,000 | $3,325,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 300,000 | $3,321,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 381,500 | $3,025,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 300,000 | $2,946,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 2,400,000 | $2,904,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 660,000 | $2,267,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 22,500 | $1,603,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 13,500 | $1,044,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC COM | 903214104 | COM | 410,000 | $959,000 | thousands by filing date | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 615,000 | $947,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 107,500 | $913,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-20-021547 | this filing | 2020-11-16 | acceptance time not in the bulk data set |